Hjem › Dermatomyositt › Maryland
Kliniske studier for Dermatomyositt i Maryland
9 studier for Dermatomyositt søker deltakere på steder i Maryland.
Byer i Maryland
Offisiell studietekst (engelsk)
FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 2
Alder 18 til 60 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07111065Environmental Risk Factors for the Anti-synthetase Syndrome
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 2 til 100 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT01276470A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
- Research Site, Baltimore
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06455449Natural History of Inflammatory Muscle Diseases
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 2 til 120 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT05738824Adult and Juvenile Myositis
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 2 til 100 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT00017914Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT03816345RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- National Institutes of Health - Accepting Adult and Juvenile Patients, Bethesda
RekruttererFase 2/3
Alder 6 til 75 · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06154252A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Johns Hopkins Hospital, Baltimore
RekruttererFase 1
Alder 18 til 74 · Alle kjønn · Oppdatert 10. sep. 2026 · NCT07085104Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- Johns Hopkins University, Baltimore
RekruttererFase 1
Alder 18 til 85 · Alle kjønn · Oppdatert 22. jul. 2026 · NCT06371417Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.